According to our new market research study on “Nasal Delivery Devices Market to 2027 – Global Analysis and Forecast – by Drug Type, Delivery Technologies, and End User,” the market is expected to reach US$ 95,676.62 million by 2027 from US$ 58,502.18 million in 2019. The market is estimated to grow with a CAGR of 6.4% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
Get Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPRE00014905/
Based on delivery technologies, the market is segmented in to spray, nebulizers, inhalers, and others. In 2019, the inhalerssegment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period.An inhaler (also known as a pump, puffer, or allergy spray) is a nasal delivery device used for delivering medicines into the lungs via person’s breathing mechanism. This device helps deliver medical treatment to the targeted region of the body, thereby reducing the side effects of oral medications. There are a wide variety of inhalers that are used to treat numerous medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD). Some of the common types of inhalers include meter-dosed inhalers, dry powder inhalers, soft mist inhalers, and others. There are certain types of inhalers containing drugs in it for the treatment of asthma and COPD such as, reliever inhalers: contain bronchodilator medicines, preventer inhalers: contain a steroid medicine.
Top Companies Overview- GlaxoSmithKline plc; AstraZeneca; Pfizer Inc; BD; Sanofi; Merck & Co, Inc.; Cadila Pharmaceuticals Ltd; Novartis AG; Dr. Reddy’s Laboratories;and Neurelis, Inc.are among the leading companies operating in the nasal delivery devices market.
Check Exclusive Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00014905/
The initial proof-of-concept studies using novel nasal drug delivery devices showed promising results in the treatment of respiratory diseases, neurological disorders, and others. Drug delivery devices play an essential role in ensuring the delivery of entire drug to the target site in the nasal cavity. In the last few decades, several innovative drug delivery approaches have been introduced that might overcome the challenges involved in crossing the blood-brain barrier (BBB). Several scientific studies support the speculation that the delivery of drugs through the nasal route may allow higher concentrations of drugs to cross the BBB. The, rising incidence of neurological disorders would increase the demand for nasal delivery devices. According to the American Society of Clinical Oncology (ASCO), in 2020, ~3,540 brain and other CNS tumors have been diagnosed in children belonging to the age group of 0–14 years, in the US. The report also stated that the brain and other CNS tumors are the second most common cancers among children, accounting for ~26% of cancer cases in children with <15 years of age.
The Report Segments Global Nasal Delivery Devices Market as Follows:
By Drug Type
- Anaesthetics
- Antibiotics
- Pain Relief Drugs
- Calcium Supplements
- Vasoconstrictors
- Antihistamines
- Others
By Delivery Technologies
- Spray
- Nebulizers
- Inhalers
- Others
By End User
- Home Care Settings
- Hospitals
- Clinics
Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPRE00014905/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876